| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Igor Bilinsky is Chief Operating Officer at IOVA. Igor Bilinsky's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.3M at current prices.
Igor Bilinsky has 35 Form 4 filings on record from January 2017 to September 2026, across 2 companies: Chief Operating Officer at Iovance Biotherapeutics (IOVA), 2021–2026; Chief Operating Officer at Armata Pharmaceuticals (ARMP), 2017.
The 68 reported transactions were 27 option exercises, 27 tax withholdings and 14 option or other derivative awards.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria